Does Necroptosis Play a Role in Inflammation and Aging

坏死性凋亡在炎症和衰老中起作用吗

基本信息

  • 批准号:
    10454859
  • 负责人:
  • 金额:
    --
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2019
  • 资助国家:
    美国
  • 起止时间:
    2019-04-01 至 2023-09-30
  • 项目状态:
    已结题

项目摘要

Chronic, low-grade inflammation (inflammaging) is a hallmark of aging and is a major risk factor for both morbidity and mortality in the elderly humans. In addition, inflammation is a major risk factor for a variety of age-related diseases, e.g. type 2 diabetes, cardiovascular disease, cancer, neurodegenerative diseases, frailty, etc. Despite the link between inflammation, aging, and age-associated diseases, we do not know the molecular mechanism(s)/pathway(s) responsible for the chronic, low-grade inflammation seen in old animals and whether the increase in chronic inflammation is a causative factor in aging and age-related diseases. Necroptosis is a recently identified pathway of programmed necrosis that induces cell death through the lysis of cells, resulting in the release of damage-associated molecular patterns (DAMPs) from the dead cells. DAMPs are potent inducers of inflammation, and circulating DAMPs have been shown to increase with age in humans and to be strongly correlated to the level of inflammation in the individual. We hypothesize that necroptosis plays a role in chronic, low-grade inflammation, which occurs with age, and preventing necroptosis will attenuate inflammation, leading to increased lifespan, improved healthspan, and reduced age-related pathology. We will use genetically modified mouse models and a pharmacological intervention to block/reduce apoptosis by targeting the receptor-interacting protein kinases (RIPK) 1 or 2 and mixed lineage kinase domain like (MLKL) protein, which are involved in the initiation of necroptosis. Aim1. Determine the role of necroptosis in chronic inflammation that occurs with age and the types of cells undergoing necroptosis. We will determine the effect of reducing necroptosis either genetically (using Ripk3+/-, Ripk3-/-, Mlkl+/-, and Mlkl-/- mice) or pharmacologically (treating with necrostatin-1s, a RIPK1 inhibitor) on inflammation. We will also identify the cell type(s) that undergo necroptosis in selected tissues of old mice. Based on our hypothesis, we predict that those tissues showing an up-regulation in necroptosis with age will show an increase in production of proinflammatory cytokines and reducing/blocking necroptosis will decrease inflammation in these tissues as well as circulating levels of proinflammatory cytokines. Aim2. Identify the pathways that increase necroptosis with age and determine the mechanism(s) that mediates the age-related increase in inflammation arising from necroptosis. TNFα, oxidative stress, and mTOR signaling have been proposed to initiate necroptosis, and these pathways increase with age. In Aim 2, we determine the role of these pathways play in the age-related increase in necroptosis using specific inhibitors to each of the pathways. DAMPs released by necroptotic cells induce inflammation through activation of three pathways: the IKK-NF-κB, MAPK-AP1 and inflammasome pathways. In Aim 2, we will also assess the effect of age on the activation of these pathways in various tissues of WT mice and determine which of the pathways are reduced when necroptosis is reduced/blocked in Ripk3 and Mlkl knockout mice or by necrostatin-1s treatment. Aim3. Determine the role of necroptosis in aging. In Aim 3, two groups of mice in which necroptosis has been blocked/reduced will be compared to wildtype mice. Mouse models (e.g., Ripk3 and/or Mlkl knockout mice) will be used that we find block inflammaging in Aim 1. The lifespan, healthspan (e.g., activity, rotarod performance, grip strength, insulin sensitivity, cognition, etc.), and age-associated pathology of these mice will be compared to WT mice. Based on our hypothesis, we predict that reducing/blocking necroptosis will retard aging as shown by improved healthspan, reduced pathology, and increased lifespan. These data would provide the first direct evidence that necroptosis induced inflammation is directly involved in aging and that chronic, low-grade inflammation plays a role in aging and the increase in pathology and age-related diseases.
慢性低度炎症(炎症)是衰老的标志,也是两者的主要危险因素 老年人的发病率和死亡率。此外,炎症是多种疾病的主要危险因素。 与年龄相关的疾病,例如2型糖尿病、心血管疾病、癌症、神经变性疾病, 尽管炎症,衰老和年龄相关疾病之间存在联系,但我们不知道 在老年动物中观察到的慢性、低度炎症的分子机制/途径 以及慢性炎症的增加是否是衰老和与年龄有关的疾病的致病因素。 坏死性凋亡是最近发现的一种程序性坏死途径,其通过裂解诱导细胞死亡, 导致死亡细胞释放损伤相关分子模式(DAMP)。 DAMPs是炎症的有效诱导物,并且循环DAMPs已被证明随着年龄的增长而增加。 并且与个体中的炎症水平强烈相关。我们假设 坏死性凋亡在慢性低度炎症中起作用,这种炎症随着年龄的增长而发生, 坏死性凋亡将减轻炎症,从而延长寿命,改善健康状况, 减少与年龄相关的病理学。我们将使用转基因小鼠模型和药理学方法, 通过靶向受体相互作用蛋白激酶(RIPK)1或2进行干预以阻断/减少细胞凋亡, 混合谱系激酶结构域样(MLKL)蛋白,其参与坏死性凋亡的起始。 目标1.确定坏死性凋亡在随着年龄增长而发生的慢性炎症中的作用, 细胞坏死我们将确定减少坏死性凋亡的影响,无论是遗传(使用 Ripk 3 +/-、Ripk 3-/-、Mlkl+/-和Mlkl-/-小鼠)或RIPK(用坏死抑素-1s(一种RIPK 1抑制剂)治疗) 关于炎症我们还将鉴定在老年小鼠的选定组织中经历坏死性凋亡的细胞类型。 基于我们的假设,我们预测随着年龄的增长,坏死性凋亡的组织表达上调, 显示促炎细胞因子产生的增加和减少/阻断坏死性凋亡将减少 这些组织中的炎症以及促炎细胞因子的循环水平。 目标2。确定随着年龄增长而增加坏死性凋亡的途径,并确定 介导由坏死性凋亡引起的与年龄相关的炎症增加。TNFα、氧化应激和 已经提出mTOR信号传导启动坏死性凋亡,并且这些途径随着年龄增加而增加。在目标2中, 我们确定这些途径在与年龄相关的坏死性凋亡增加中的作用, 抑制剂的每一个途径。坏死性凋亡细胞释放的DAMP通过以下途径诱导炎症: IKK-NF-κB、MAPK-AP 1和炎性小体通路。在目标2中,我们还将 评估年龄对WT小鼠各种组织中这些途径活化的影响,并确定 当在Ripk 3和Mlkl敲除小鼠中减少/阻断坏死性凋亡时,哪些途径减少,或者 necrostatin-1 s治疗。 目标3。确定坏死性凋亡在衰老中的作用。在目标3中,两组小鼠中, 将被阻断/减少的小鼠与野生型小鼠进行比较。小鼠模型(例如,Ripk 3和/或Mlkl敲除 小鼠)将被使用,我们发现在Aim 1中阻断炎症。寿命、健康寿命(例如,活动,旋转棒 性能、握力、胰岛素敏感性、认知等),这些小鼠的年龄相关病理学将 与WT小鼠相比。基于我们的假设,我们预测减少/阻断坏死性凋亡将延缓 衰老,表现为改善的健康寿命、减少的病理和增加的寿命。这些数据将 提供了第一个直接证据,即坏死性凋亡诱导的炎症直接参与衰老, 慢性、低度炎症在衰老和病理学和年龄相关疾病的增加中起作用。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ARLAN G. RICHARDSON其他文献

ARLAN G. RICHARDSON的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ARLAN G. RICHARDSON', 18)}}的其他基金

BLR&D Research Career Scientist Award Application
BLR
  • 批准号:
    10451497
  • 财政年份:
    2020
  • 资助金额:
    --
  • 项目类别:
BLR&D Research Career Scientist Award Application
BLR
  • 批准号:
    10618254
  • 财政年份:
    2020
  • 资助金额:
    --
  • 项目类别:
Does Necroptosis Play a Role in Inflammation and Aging
坏死性凋亡在炎症和衰老中起作用吗
  • 批准号:
    9913983
  • 财政年份:
    2019
  • 资助金额:
    --
  • 项目类别:
Does Necroptosis Play a Role in Inflammation and Aging
坏死性凋亡在炎症和衰老中起作用吗
  • 批准号:
    10166597
  • 财政年份:
    2019
  • 资助金额:
    --
  • 项目类别:
ShEEP Request for Cell Sorter
ShEEP 请求细胞分选仪
  • 批准号:
    9906780
  • 财政年份:
    2019
  • 资助金额:
    --
  • 项目类别:
ADMINISTRATIVE SUPPLEMENT TO GRANT R01-AG057424, Short-term Measurements of Physical Resilience as a Predictor of Healthspan in Mice.
授予 R01-AG057424 的行政补充,短期身体弹性测量作为小鼠健康寿命的预测因子。
  • 批准号:
    9752040
  • 财政年份:
    2017
  • 资助金额:
    --
  • 项目类别:
TESTING THE ABILITY OF NOVEL ASSAYS OF RESILIENCE TO PREDICT LIFESPAN
测试新的弹性分析方法预测寿命的能力
  • 批准号:
    10165438
  • 财政年份:
    2017
  • 资助金额:
    --
  • 项目类别:
Oklahoma Nathan Shock Center of Excellence in Basic Biology of Aging
俄克拉荷马州内森休克衰老基础生物学卓越中心
  • 批准号:
    10404833
  • 财政年份:
    2015
  • 资助金额:
    --
  • 项目类别:
Oklahoma Nathan Shock Center of Excellence in Basic Biology of Aging
俄克拉荷马州内森休克衰老基础生物学卓越中心
  • 批准号:
    9110089
  • 财政年份:
    2015
  • 资助金额:
    --
  • 项目类别:
Program Enhancement Core
程序增强核心
  • 批准号:
    10424597
  • 财政年份:
    2015
  • 资助金额:
    --
  • 项目类别:

相似国自然基金

靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 批准年份:
    2025
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 批准年份:
    2025
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
  • 批准年份:
    2024
  • 资助金额:
    0 万元
  • 项目类别:
    面上项目
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
  • 批准号:
    2023JJ50274
  • 批准年份:
    2023
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    33 万元
  • 项目类别:
    地区科学基金项目
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
  • 批准号:
    n/a
  • 批准年份:
    2022
  • 资助金额:
    10.0 万元
  • 项目类别:
    省市级项目
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
  • 批准号:
    81973577
  • 批准年份:
    2019
  • 资助金额:
    55.0 万元
  • 项目类别:
    面上项目
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
  • 批准号:
    81602908
  • 批准年份:
    2016
  • 资助金额:
    18.0 万元
  • 项目类别:
    青年科学基金项目
高血糖激活滑膜AGE-RAGE-PKC轴致骨关节炎易感的机制研究
  • 批准号:
    81501928
  • 批准年份:
    2015
  • 资助金额:
    18.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Collaborative Research: Resolving the LGM ventilation age conundrum: New radiocarbon records from high sedimentation rate sites in the deep western Pacific
合作研究:解决LGM通风年龄难题:西太平洋深部高沉降率地点的新放射性碳记录
  • 批准号:
    2341426
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Continuing Grant
Collaborative Research: Resolving the LGM ventilation age conundrum: New radiocarbon records from high sedimentation rate sites in the deep western Pacific
合作研究:解决LGM通风年龄难题:西太平洋深部高沉降率地点的新放射性碳记录
  • 批准号:
    2341424
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Continuing Grant
PROTEMO: Emotional Dynamics Of Protective Policies In An Age Of Insecurity
PROTEMO:不安全时代保护政​​策的情绪动态
  • 批准号:
    10108433
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    EU-Funded
The role of dietary and blood proteins in the prevention and development of major age-related diseases
膳食和血液蛋白在预防和发展主要与年龄相关的疾病中的作用
  • 批准号:
    MR/X032809/1
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Fellowship
Atomic Anxiety in the New Nuclear Age: How Can Arms Control and Disarmament Reduce the Risk of Nuclear War?
新核时代的原子焦虑:军控与裁军如何降低核战争风险?
  • 批准号:
    MR/X034690/1
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Fellowship
Walkability and health-related quality of life in Age-Friendly Cities (AFCs) across Japan and the Asia-Pacific
日本和亚太地区老年友好城市 (AFC) 的步行适宜性和与健康相关的生活质量
  • 批准号:
    24K13490
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Discovering the (R)Evolution of EurAsian Steppe Metallurgy: Social and environmental impact of the Bronze Age steppes metal-driven economy
发现欧亚草原冶金的(R)演变:青铜时代草原金属驱动型经济的社会和环境影响
  • 批准号:
    EP/Z00022X/1
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Research Grant
ICF: Neutrophils and cellular senescence: A vicious circle promoting age-related disease.
ICF:中性粒细胞和细胞衰老:促进与年龄相关疾病的恶性循环。
  • 批准号:
    MR/Y003365/1
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Research Grant
Doctoral Dissertation Research: Effects of age of acquisition in emerging sign languages
博士论文研究:新兴手语习得年龄的影响
  • 批准号:
    2335955
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Standard Grant
Shaping Competition in the Digital Age (SCiDA) - Principles, tools and institutions of digital regulation in the UK, Germany and the EU
塑造数字时代的竞争 (SCiDA) - 英国、德国和欧盟的数字监管原则、工具和机构
  • 批准号:
    AH/Y007549/1
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了